---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-055829"
form_type: "8-K"
ticker: "ISPC"
cik: "0001558569"
company_name: "iSpecimen Inc."
filed_at: "2023-05-04T23:59:59+00:00"
generated_at: "2026-06-15T21:51:48.186360+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# iSpecimen reports Q1 revenue of $3.0M (+17% YoY); net loss flat at $2.4M

## Summary
- Revenue $3.0M vs $2.5M in Q1 2022, a 17% increase; specimen count up 75% but ASP down 30%.
- Net loss $2.4M ($0.27 per share), unchanged YoY; cash, equivalents and securities totaled $11M at Mar 31 vs $15.3M at Dec 31.
- Unique customer organizations reached 534 (+22%); registered marketplace users ~6,900 (+24%).
- CEO Tracy Curley cited progress on adjacent revenue opportunities and technology investment.

## SEC filing metadata
- accession: 0001104659-23-055829
- form_type: 8-K
- ticker: ISPC
- cik: 0001558569
- company_name: iSpecimen Inc.
- filed_at: 2023-05-04T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1558569/000110465923055829/0001104659-23-055829-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1558569/000110465923055829/tm2314591d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-055829
- JSON: https://secwatch.observer/filing/0001104659-23-055829.json
- Plain text: https://secwatch.observer/filing/0001104659-23-055829.txt

## Key facts
- Earnings Releases
  iSpecimen Inc. reported first quarter of 2023 results: revenue Revenue was approximately $3.0 million, net income Net loss was approximately $2.4 million, or $(0.27) per share, EPS $(0.27) per share.
  - Period: first quarter of 2023
  - Revenue: Revenue was approximately $3.0 million
  - Net income: Net loss was approximately $2.4 million, or $(0.27) per share
  - EPS: $(0.27) per share
  - Result: reported results
  source text: reported its financial and operating results for the three-month period ended March 31, 2023. “I am pleased to report that iSpecimen delivered strong revenue of approximately $3.0 million, a 17% increase year-over-year for the first quarter of 2023, which met our internal expectations and reflects the seasonality of our business,” said Tracy Curley, CEO and CFO.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1558569/000110465923055829/0001104659-23-055829-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.